OABI OmniAb, Inc.: Rasio rega marang prakiraan pendapatan

OmniAb Corp - logo grafis emiten OABI

OmniAb, Inc. (OABI) attracts leading biologists and engineers through innovative SaaS solutions and stock options. Analyzing the chart on GURU.Markets, we find that the issuer's forward P/S has reached 17.80. A robust patent shield and unique platforms create an insurmountable barrier to entry for competitors. However, geopolitical tensions and logistics disruptions are hindering global tests, thereby reducing licensing payments.

OABI omniab.com: Kapitalisasi marang prakiraan pendapatan ing interval 28.04.2023 - 17.11.2026

Rincian metrik lan analitis perusahaan OmniAb, Inc. (OABI)

- rega pasar lan target rega analis:
Ringkesan analitik perusahaan:OmniAb Corp (OABI)
Sampel barang OmniAb Inc

The forward P/S ratio determines the market value of an asset relative to expected revenue, allowing an investor to assess the extent of the premium paid for future cash flows. By analyzing the forward P/S based on forecasts, one can understand to what extent the market prices in the success of OmniAb, Inc. (OABI) and its unique bio-factories for creating human antibodies, which radically accelerate the development of anti-cancer drugs for the largest pharmaceutical behemoths.